# European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

> **NCT04504006** · — · RECRUITING · sponsor: **Dr. Paul Buderath** · enrollment: 500 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **PROCEDURE:** Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL)

## Key facts

- **NCT ID:** NCT04504006
- **Lead sponsor:** Dr. Paul Buderath
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-10-10
- **Primary completion:** 2025-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04504006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04504006, "European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04504006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*